Showing posts with label birth. Show all posts
Showing posts with label birth. Show all posts

Saturday, April 16, 2011

Birth after TESE-ICSI in a man with hypogonadotropic hypogonadism and congenital adrenal hypoplasia linked to a DAX-1 (NR0B1) mutation

Skip Navigation

C. Frapsauce1, C. Ravel1, M. Legendre2, M. Sibony3, J. Mandelbaum1, B. Donadille4, J.C. Achermann5, J.-P. Siffroi2,6 and S. Christin-Maitre4,6,*
1UPMC, AP-HP, Hôpital Tenon, Service de Biologie de la Reproduction, 75020 Paris, France
2AP-HP, Hôpital Trousseau, Service de Génétique et d'Embryologie Médicales, 75012 Paris, France
3AP-HP, Hôpital Tenon, Service d'Anatomopathologie, 75020 Paris, France
4Service d'Endocrinologie, Hôpital Saint-Antoine, AP-HP, Centre de maladies endocriniennes rares de la croissance CMERC, 75012 Paris, France
5Developmental Endocrinology Research Group, Clinical & Molecular Genetics, UCL Institute of Child Health, University College London, London WC1N 1EH, UK
6ER9, génétique de la reproduction, Faculté de médecine Pierre et Marie Curie, University Paris VI, France *Correspondence address. Service d'Endocrinologie, Hôpital Saint-Antoine, AP-HP, Centre de maladies rares de la croissance (CMERC), 184 rue du faubourg Saint-Antoine, ER-9 Université Paris VI, 75012 Paris, France. Tel: +33-1-49-28-24-00; Fax: +33-1-49-28-31-95; E-mail: sophie.christin-maitre{at}sat.aphp.frReceived July 4, 2010. Revision received November 30, 2010. Accepted December 3, 2010. DAX1/NR0B1 mutations are responsible for X-linked congenital adrenal hypoplasia (AHC) associated with hypogonadotropic hypogonadism (HH). Few data are available concerning testicular function and fertility in men with DAX1 mutations. Azoospermia as well as failure of gonadotrophin treatment have been reported. We induced spermatogenesis in a patient who has a DAX1 mutation (c.1210C>T), leading to a stop codon in position 404 (p.Gln404X). His endocrine testing revealed a low testosterone level at 1.2 nmol/l (N: 12–40) with low FSH and LH levels at 2.1 IU/l (N: 1–5 IU/l) and 0.1 IU/l (N: 1–4 IU/l), respectively. Baseline semen analysis revealed azoospermia. Menotropin (Menopur®:150 IU, three times weekly) and human chorionic gonadotrophin (1500 IU, twice weekly) were used. After 20 months of treatment, as azoospermia persisted, bilateral multiple site testicular biopsies were performed. Histology revealed severe hypospermatogenesis. Rare spermatozoa were extracted from the right posterior fragment and ICSI was performed. Four embryos were obtained and, after a frozen–thawed single-embryo transfer, the patient's wife became pregnant and gave birth to a healthy boy. We report the first case of paternity after TESE–ICSI in a patient with DAX1 mutation, giving potential hope to these patients to father non-affected children. Furthermore, this case illustrates the fact that patients with X-linked AHC have a primary testicular defect in addition to HH.

© The Author 2011. Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology.This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/2.5), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

This ArticleHum. Reprod. (2011) 26 (3): 724-728. doi: 10.1093/humrep/deq372 First published online: January 11, 2011

Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.



View the original article here



Peliculas Online

Read More..

Tuesday, March 29, 2011

Dietary iron intake during early pregnancy and birth outcomes in a cohort of British women

Skip Navigation

Nisreen A. Alwan1,*, Darren C. Greenwood2, Nigel A.B. Simpson3, Harry J. McArdle4, Keith M. Godfrey5,6 and Janet E. Cade1
1Nutritional Epidemiology Group, Centre for Epidemiology and Biostatistics, School of Food Science and Nutrition, University of Leeds, Leeds, LS2 9JT, UK
2Division of Biostatistics, Centre for Epidemiology and Biostatistics, University of Leeds, Leeds, UK
3Department of Obstetrics and Gynaecology, University of Leeds, Leeds, UK
4Rowett Institute of Nutrition and Health, University of Aberdeen, Aberdeen, UK
5MRC Lifecourse Epidemiology Unit, Southampton, UK
6NIHR Nutrition, Diet & Lifestyle Biomedical Research Unit, Southampton, UK *Correspondence address. Tel: +44-113-343-6990; Fax: +44-113-343-4877; E-mail: n.alwan{at}leeds.ac.ukReceived October 10, 2010. Revision received November 13, 2010. Accepted December 20, 2010. BACKGROUND Iron deficiency during pregnancy is associated with adverse birth outcomes, particularly, if present during early gestation. Iron supplements are widely recommended during pregnancy, but evidence of their benefit in relation to infant outcomes is not established. This study was performed in the UK, where iron supplements are not routinely recommended during pregnancy, to investigate the association between iron intake in pregnancy and size at birth.

METHODS From a prospective cohort of 1274 pregnant women aged 18–45 years, dietary intake was reported in a 24-h recall administered by a research midwife at 12-week gestation. Dietary supplement intake was ascertained using dietary recall and three questionnaires in the first, second and third trimesters.

RESULTS Of the cohort of pregnant women, 80% reported dietary iron intake below the UK Reference Nutrient Intake of 14.8 mg/day. Those reported taking iron-containing supplements in the first, second and third trimesters were 24, 15 and 8%, respectively. Women with dietary iron intake >14.8 mg/day were more likely to be older, have a higher socioeconomic profile and take supplements during the first trimester. Vegetarians were less likely to have low dietary iron intake [odds ratio = 0.5, 95% confidence interval (CI): 0.4, 0.8] and more likely to take supplements during the first and second trimesters. Total iron intake, but not iron intake from food only, was associated with birthweight centile (adjusted change = 2.5 centiles/10 mg increase in iron, 95% CI: 0.4, 4.6). This association was stronger in the high vitamin C intake group, but effect modification was not significant.

CONCLUSION There was a positive relationship between total iron intake, from food and supplements, in early pregnancy and birthweight. Iron intake, both from diet and supplements, during the first trimester of pregnancy was higher in vegetarians and women with a better socioeconomic profile.

© The Author 2011. Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology.This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/2.5), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

This ArticleHum. Reprod. (2011) 26 (4): 911-919. doi: 10.1093/humrep/der005 First published online: February 7, 2011

Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.



View the original article here



Peliculas Online

Read More..